Cadila Healthcare Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 44118.12 Crore) operating in Pharm...

Cadila Healthcare Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 48663.53 Crore) operating in Pharm...

Promoters held 74.9 per cent stake in the company as of June 30, 2020, while FIIs held 4.6 per cent, DIIs 12.6 per cent and public and othe...

Fewer Chinese startups going public, uncertainty after trade spat with US & sobering of valuations post WeWork.

The expansion will involve a mix of large and smaller format outlets, the latter to tap captive markets with relatively lower spending such...

Chinese investors have armed themselves with a suite of services for their portfolio companies in India.

Buy Cadila Healthcare at a price target of Rs 400.

The Series-C round was led by CDH Investments and MorningSide Group, with Chinese recommerce firm AiHuiShou participating as a strategic in...

Nearly half-a-dozen venture capital funds from China are looking to buy stakes in Indian startups across financial and education technology...

Hold Cadila Healthcare Ltd. at a price target of Rs 380.0 .

Buy Cadila Healthcare, at a price target of Rs 460.

Buy Cadila Healthcare Ltd. at a price target of Rs 444.0 .

Buy Cadila Healthcare Ltd. at a price target of Rs 600. Edelweiss says Cadila's US business growth will be best-in-class at 48 per cent wit...

Drug maker Ranbaxy Laboratories today announced receipt of approval from Health Canada to sell generic version of Pfizer's Aricept.

India Infoline has maintained its ‘Buy’ rating on Radico Khaitan with a target price of Rs 160.

The US partner, Wabco and TVS group are set to part ways by totally divesting their balance stake in favour of each other in the two joint ...

Goldman Sachs has paid $120 million for a 25 percent stake in Chinese cement maker Hongshi Group, the media reported.